nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—ABCG2—Omeprazole—Barrett's esophagus	0.213	0.632	CbGbCtD
Vandetanib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0779	0.232	CbGbCtD
Vandetanib—CYP3A4—Omeprazole—Barrett's esophagus	0.0459	0.136	CbGbCtD
Vandetanib—ORM1—bile—Barrett's esophagus	0.0176	0.119	CbGeAlD
Vandetanib—ERBB3—exocrine gland—Barrett's esophagus	0.0104	0.07	CbGeAlD
Vandetanib—Erlotinib—NR1I2—Barrett's esophagus	0.00973	1	CrCbGaD
Vandetanib—Dysaesthesia—Omeprazole—Barrett's esophagus	0.0068	0.0208	CcSEcCtD
Vandetanib—Dysaesthesia—Esomeprazole—Barrett's esophagus	0.0068	0.0208	CcSEcCtD
Vandetanib—PTK6—digestive system—Barrett's esophagus	0.00604	0.0407	CbGeAlD
Vandetanib—BMPR1B—epithelium—Barrett's esophagus	0.00602	0.0406	CbGeAlD
Vandetanib—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.00494	0.0151	CcSEcCtD
Vandetanib—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.00494	0.0151	CcSEcCtD
Vandetanib—Polyp—Esomeprazole—Barrett's esophagus	0.00483	0.0148	CcSEcCtD
Vandetanib—Polyp—Omeprazole—Barrett's esophagus	0.00483	0.0148	CcSEcCtD
Vandetanib—FLT4—epithelium—Barrett's esophagus	0.00474	0.032	CbGeAlD
Vandetanib—RIPK2—epithelium—Barrett's esophagus	0.00472	0.0318	CbGeAlD
Vandetanib—EPHA5—digestive system—Barrett's esophagus	0.00467	0.0315	CbGeAlD
Vandetanib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.00463	0.0141	CcSEcCtD
Vandetanib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.00463	0.0141	CcSEcCtD
Vandetanib—VEGFA—smooth muscle tissue—Barrett's esophagus	0.00453	0.0306	CbGeAlD
Vandetanib—ERBB3—epithelium—Barrett's esophagus	0.00451	0.0305	CbGeAlD
Vandetanib—Cyst—Esomeprazole—Barrett's esophagus	0.0044	0.0134	CcSEcCtD
Vandetanib—Cyst—Omeprazole—Barrett's esophagus	0.0044	0.0134	CcSEcCtD
Vandetanib—RET—epithelium—Barrett's esophagus	0.00419	0.0282	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—Barrett's esophagus	0.00402	0.0271	CbGeAlD
Vandetanib—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00384	0.0117	CcSEcCtD
Vandetanib—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00384	0.0117	CcSEcCtD
Vandetanib—TEK—epithelium—Barrett's esophagus	0.00381	0.0257	CbGeAlD
Vandetanib—Fungal infection—Omeprazole—Barrett's esophagus	0.00381	0.0116	CcSEcCtD
Vandetanib—Fungal infection—Esomeprazole—Barrett's esophagus	0.00381	0.0116	CcSEcCtD
Vandetanib—FYN—smooth muscle tissue—Barrett's esophagus	0.00376	0.0254	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—Barrett's esophagus	0.00368	0.0248	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—Barrett's esophagus	0.00368	0.0248	CbGeAlD
Vandetanib—RIPK2—digestive system—Barrett's esophagus	0.00359	0.0242	CbGeAlD
Vandetanib—FMO1—digestive system—Barrett's esophagus	0.00356	0.024	CbGeAlD
Vandetanib—ERBB3—digestive system—Barrett's esophagus	0.00343	0.0232	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—Barrett's esophagus	0.00339	0.0229	CbGeAlD
Vandetanib—SRC—epithelium—Barrett's esophagus	0.00339	0.0229	CbGeAlD
Vandetanib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00335	0.0102	CcSEcCtD
Vandetanib—Proteinuria—Omeprazole—Barrett's esophagus	0.00335	0.0102	CcSEcCtD
Vandetanib—Protein urine present—Omeprazole—Barrett's esophagus	0.0033	0.0101	CcSEcCtD
Vandetanib—Protein urine present—Esomeprazole—Barrett's esophagus	0.0033	0.0101	CcSEcCtD
Vandetanib—SRC—smooth muscle tissue—Barrett's esophagus	0.00327	0.022	CbGeAlD
Vandetanib—MKNK1—digestive system—Barrett's esophagus	0.00322	0.0218	CbGeAlD
Vandetanib—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00321	0.00982	CcSEcCtD
Vandetanib—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00321	0.00982	CcSEcCtD
Vandetanib—FGR—digestive system—Barrett's esophagus	0.00319	0.0215	CbGeAlD
Vandetanib—RET—digestive system—Barrett's esophagus	0.00319	0.0215	CbGeAlD
Vandetanib—KDR—epithelium—Barrett's esophagus	0.00312	0.021	CbGeAlD
Vandetanib—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00309	0.00944	CcSEcCtD
Vandetanib—Creatinine increased—Omeprazole—Barrett's esophagus	0.00309	0.00944	CcSEcCtD
Vandetanib—KDR—smooth muscle tissue—Barrett's esophagus	0.003	0.0203	CbGeAlD
Vandetanib—FYN—digestive system—Barrett's esophagus	0.00297	0.02	CbGeAlD
Vandetanib—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00287	0.00878	CcSEcCtD
Vandetanib—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00287	0.00878	CcSEcCtD
Vandetanib—Cystitis—Esomeprazole—Barrett's esophagus	0.00284	0.00868	CcSEcCtD
Vandetanib—Cystitis—Omeprazole—Barrett's esophagus	0.00284	0.00868	CcSEcCtD
Vandetanib—Dry eye—Omeprazole—Barrett's esophagus	0.00272	0.0083	CcSEcCtD
Vandetanib—Dry eye—Esomeprazole—Barrett's esophagus	0.00272	0.0083	CcSEcCtD
Vandetanib—PDGFRB—epithelium—Barrett's esophagus	0.0027	0.0182	CbGeAlD
Vandetanib—YES1—digestive system—Barrett's esophagus	0.00268	0.0181	CbGeAlD
Vandetanib—Bladder pain—Esomeprazole—Barrett's esophagus	0.00266	0.00812	CcSEcCtD
Vandetanib—Bladder pain—Omeprazole—Barrett's esophagus	0.00266	0.00812	CcSEcCtD
Vandetanib—Neoplasm—Omeprazole—Barrett's esophagus	0.00266	0.00812	CcSEcCtD
Vandetanib—Neoplasm—Esomeprazole—Barrett's esophagus	0.00266	0.00812	CcSEcCtD
Vandetanib—STK10—digestive system—Barrett's esophagus	0.00266	0.0179	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.0026	0.0175	CbGeAlD
Vandetanib—SRC—digestive system—Barrett's esophagus	0.00258	0.0174	CbGeAlD
Vandetanib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00241	0.00736	CcSEcCtD
Vandetanib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00241	0.00736	CcSEcCtD
Vandetanib—KDR—digestive system—Barrett's esophagus	0.00237	0.016	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00232	0.0156	CbGeAlD
Vandetanib—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00219	0.00668	CcSEcCtD
Vandetanib—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00219	0.00668	CcSEcCtD
Vandetanib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00214	0.00655	CcSEcCtD
Vandetanib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00214	0.00655	CcSEcCtD
Vandetanib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00213	0.00652	CcSEcCtD
Vandetanib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00213	0.00652	CcSEcCtD
Vandetanib—PDGFRB—digestive system—Barrett's esophagus	0.00205	0.0138	CbGeAlD
Vandetanib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.002	0.00611	CcSEcCtD
Vandetanib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.002	0.00611	CcSEcCtD
Vandetanib—Dry skin—Omeprazole—Barrett's esophagus	0.00196	0.00598	CcSEcCtD
Vandetanib—Dry skin—Esomeprazole—Barrett's esophagus	0.00196	0.00598	CcSEcCtD
Vandetanib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00194	0.00594	CcSEcCtD
Vandetanib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00194	0.00594	CcSEcCtD
Vandetanib—Gastritis—Esomeprazole—Barrett's esophagus	0.00189	0.00577	CcSEcCtD
Vandetanib—Gastritis—Omeprazole—Barrett's esophagus	0.00189	0.00577	CcSEcCtD
Vandetanib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00188	0.00575	CcSEcCtD
Vandetanib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00188	0.00575	CcSEcCtD
Vandetanib—Influenza—Omeprazole—Barrett's esophagus	0.00184	0.00564	CcSEcCtD
Vandetanib—Dysphagia—Omeprazole—Barrett's esophagus	0.00184	0.00564	CcSEcCtD
Vandetanib—Influenza—Esomeprazole—Barrett's esophagus	0.00184	0.00564	CcSEcCtD
Vandetanib—Dysphagia—Esomeprazole—Barrett's esophagus	0.00184	0.00564	CcSEcCtD
Vandetanib—ABL1—digestive system—Barrett's esophagus	0.00183	0.0123	CbGeAlD
Vandetanib—Bronchospasm—Omeprazole—Barrett's esophagus	0.00181	0.00555	CcSEcCtD
Vandetanib—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00181	0.00555	CcSEcCtD
Vandetanib—Pancreatitis—Omeprazole—Barrett's esophagus	0.00181	0.00553	CcSEcCtD
Vandetanib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00181	0.00553	CcSEcCtD
Vandetanib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00172	0.00527	CcSEcCtD
Vandetanib—Dysuria—Omeprazole—Barrett's esophagus	0.00172	0.00527	CcSEcCtD
Vandetanib—Neutropenia—Omeprazole—Barrett's esophagus	0.00172	0.00527	CcSEcCtD
Vandetanib—Dysuria—Esomeprazole—Barrett's esophagus	0.00172	0.00527	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00171	0.00524	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00171	0.00524	CcSEcCtD
Vandetanib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.0017	0.00521	CcSEcCtD
Vandetanib—Pollakiuria—Omeprazole—Barrett's esophagus	0.0017	0.00521	CcSEcCtD
Vandetanib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00168	0.00515	CcSEcCtD
Vandetanib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00168	0.00515	CcSEcCtD
Vandetanib—Weight decreased—Esomeprazole—Barrett's esophagus	0.00167	0.0051	CcSEcCtD
Vandetanib—Weight decreased—Omeprazole—Barrett's esophagus	0.00167	0.0051	CcSEcCtD
Vandetanib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00164	0.00503	CcSEcCtD
Vandetanib—Infestation—Omeprazole—Barrett's esophagus	0.00164	0.00503	CcSEcCtD
Vandetanib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00164	0.00503	CcSEcCtD
Vandetanib—Infestation—Esomeprazole—Barrett's esophagus	0.00164	0.00503	CcSEcCtD
Vandetanib—Depression—Omeprazole—Barrett's esophagus	0.00164	0.00501	CcSEcCtD
Vandetanib—Depression—Esomeprazole—Barrett's esophagus	0.00164	0.00501	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00163	0.00498	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00163	0.00498	CcSEcCtD
Vandetanib—Renal failure—Omeprazole—Barrett's esophagus	0.00162	0.00494	CcSEcCtD
Vandetanib—Renal failure—Esomeprazole—Barrett's esophagus	0.00162	0.00494	CcSEcCtD
Vandetanib—Stomatitis—Omeprazole—Barrett's esophagus	0.0016	0.0049	CcSEcCtD
Vandetanib—Stomatitis—Esomeprazole—Barrett's esophagus	0.0016	0.0049	CcSEcCtD
Vandetanib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0016	0.00489	CcSEcCtD
Vandetanib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.0016	0.00489	CcSEcCtD
Vandetanib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.0016	0.00489	CcSEcCtD
Vandetanib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0016	0.00489	CcSEcCtD
Vandetanib—Haematuria—Omeprazole—Barrett's esophagus	0.00157	0.00479	CcSEcCtD
Vandetanib—Haematuria—Esomeprazole—Barrett's esophagus	0.00157	0.00479	CcSEcCtD
Vandetanib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00156	0.00475	CcSEcCtD
Vandetanib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00156	0.00475	CcSEcCtD
Vandetanib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00155	0.00474	CcSEcCtD
Vandetanib—Epistaxis—Omeprazole—Barrett's esophagus	0.00155	0.00474	CcSEcCtD
Vandetanib—Sinusitis—Esomeprazole—Barrett's esophagus	0.00154	0.00472	CcSEcCtD
Vandetanib—Sinusitis—Omeprazole—Barrett's esophagus	0.00154	0.00472	CcSEcCtD
Vandetanib—Bradycardia—Omeprazole—Barrett's esophagus	0.0015	0.00459	CcSEcCtD
Vandetanib—Bradycardia—Esomeprazole—Barrett's esophagus	0.0015	0.00459	CcSEcCtD
Vandetanib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00146	0.00446	CcSEcCtD
Vandetanib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00146	0.00446	CcSEcCtD
Vandetanib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00145	0.00442	CcSEcCtD
Vandetanib—Urethral disorder—Omeprazole—Barrett's esophagus	0.00145	0.00442	CcSEcCtD
Vandetanib—Visual impairment—Esomeprazole—Barrett's esophagus	0.00142	0.00435	CcSEcCtD
Vandetanib—Visual impairment—Omeprazole—Barrett's esophagus	0.00142	0.00435	CcSEcCtD
Vandetanib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.0014	0.00427	CcSEcCtD
Vandetanib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.0014	0.00427	CcSEcCtD
Vandetanib—Eye disorder—Omeprazole—Barrett's esophagus	0.00138	0.00422	CcSEcCtD
Vandetanib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00138	0.00422	CcSEcCtD
Vandetanib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00133	0.00407	CcSEcCtD
Vandetanib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00133	0.00407	CcSEcCtD
Vandetanib—Alopecia—Omeprazole—Barrett's esophagus	0.0013	0.00399	CcSEcCtD
Vandetanib—Alopecia—Esomeprazole—Barrett's esophagus	0.0013	0.00399	CcSEcCtD
Vandetanib—Mental disorder—Omeprazole—Barrett's esophagus	0.00129	0.00395	CcSEcCtD
Vandetanib—Mental disorder—Esomeprazole—Barrett's esophagus	0.00129	0.00395	CcSEcCtD
Vandetanib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00129	0.00393	CcSEcCtD
Vandetanib—Malnutrition—Omeprazole—Barrett's esophagus	0.00129	0.00393	CcSEcCtD
Vandetanib—Dysgeusia—Omeprazole—Barrett's esophagus	0.00126	0.00385	CcSEcCtD
Vandetanib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00126	0.00385	CcSEcCtD
Vandetanib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00124	0.00378	CcSEcCtD
Vandetanib—Muscle spasms—Omeprazole—Barrett's esophagus	0.00124	0.00378	CcSEcCtD
Vandetanib—Vision blurred—Omeprazole—Barrett's esophagus	0.00121	0.0037	CcSEcCtD
Vandetanib—Vision blurred—Esomeprazole—Barrett's esophagus	0.00121	0.0037	CcSEcCtD
Vandetanib—Tremor—Esomeprazole—Barrett's esophagus	0.0012	0.00368	CcSEcCtD
Vandetanib—Tremor—Omeprazole—Barrett's esophagus	0.0012	0.00368	CcSEcCtD
Vandetanib—Cough—Omeprazole—Barrett's esophagus	0.00112	0.00343	CcSEcCtD
Vandetanib—Cough—Esomeprazole—Barrett's esophagus	0.00112	0.00343	CcSEcCtD
Vandetanib—Hypertension—Esomeprazole—Barrett's esophagus	0.00111	0.00339	CcSEcCtD
Vandetanib—Hypertension—Omeprazole—Barrett's esophagus	0.00111	0.00339	CcSEcCtD
Vandetanib—Chest pain—Omeprazole—Barrett's esophagus	0.00109	0.00334	CcSEcCtD
Vandetanib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00109	0.00334	CcSEcCtD
Vandetanib—Chest pain—Esomeprazole—Barrett's esophagus	0.00109	0.00334	CcSEcCtD
Vandetanib—Arthralgia—Omeprazole—Barrett's esophagus	0.00109	0.00334	CcSEcCtD
Vandetanib—Anxiety—Esomeprazole—Barrett's esophagus	0.00109	0.00333	CcSEcCtD
Vandetanib—Anxiety—Omeprazole—Barrett's esophagus	0.00109	0.00333	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00109	0.00332	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00109	0.00332	CcSEcCtD
Vandetanib—Dry mouth—Esomeprazole—Barrett's esophagus	0.00107	0.00327	CcSEcCtD
Vandetanib—Dry mouth—Omeprazole—Barrett's esophagus	0.00107	0.00327	CcSEcCtD
Vandetanib—Infection—Omeprazole—Barrett's esophagus	0.00104	0.00318	CcSEcCtD
Vandetanib—Infection—Esomeprazole—Barrett's esophagus	0.00104	0.00318	CcSEcCtD
Vandetanib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00103	0.00314	CcSEcCtD
Vandetanib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00103	0.00314	CcSEcCtD
Vandetanib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00103	0.00314	CcSEcCtD
Vandetanib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00103	0.00314	CcSEcCtD
Vandetanib—Skin disorder—Esomeprazole—Barrett's esophagus	0.00102	0.00311	CcSEcCtD
Vandetanib—Skin disorder—Omeprazole—Barrett's esophagus	0.00102	0.00311	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000956	0.00292	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000956	0.00292	CcSEcCtD
Vandetanib—Insomnia—Omeprazole—Barrett's esophagus	0.000949	0.0029	CcSEcCtD
Vandetanib—Insomnia—Esomeprazole—Barrett's esophagus	0.000949	0.0029	CcSEcCtD
Vandetanib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000942	0.00288	CcSEcCtD
Vandetanib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000942	0.00288	CcSEcCtD
Vandetanib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000935	0.00286	CcSEcCtD
Vandetanib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000935	0.00286	CcSEcCtD
Vandetanib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000923	0.00282	CcSEcCtD
Vandetanib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000923	0.00282	CcSEcCtD
Vandetanib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000912	0.00279	CcSEcCtD
Vandetanib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000912	0.00279	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000905	0.00277	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000905	0.00277	CcSEcCtD
Vandetanib—Fatigue—Omeprazole—Barrett's esophagus	0.000904	0.00276	CcSEcCtD
Vandetanib—Fatigue—Esomeprazole—Barrett's esophagus	0.000904	0.00276	CcSEcCtD
Vandetanib—Pain—Esomeprazole—Barrett's esophagus	0.000897	0.00274	CcSEcCtD
Vandetanib—Constipation—Esomeprazole—Barrett's esophagus	0.000897	0.00274	CcSEcCtD
Vandetanib—Pain—Omeprazole—Barrett's esophagus	0.000897	0.00274	CcSEcCtD
Vandetanib—Constipation—Omeprazole—Barrett's esophagus	0.000897	0.00274	CcSEcCtD
Vandetanib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000858	0.00262	CcSEcCtD
Vandetanib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000858	0.00262	CcSEcCtD
Vandetanib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000829	0.00253	CcSEcCtD
Vandetanib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000829	0.00253	CcSEcCtD
Vandetanib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000829	0.00253	CcSEcCtD
Vandetanib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000829	0.00253	CcSEcCtD
Vandetanib—CYP3A4—digestive system—Barrett's esophagus	0.000804	0.00542	CbGeAlD
Vandetanib—Asthenia—Omeprazole—Barrett's esophagus	0.000753	0.0023	CcSEcCtD
Vandetanib—Asthenia—Esomeprazole—Barrett's esophagus	0.000753	0.0023	CcSEcCtD
Vandetanib—Pruritus—Esomeprazole—Barrett's esophagus	0.000742	0.00227	CcSEcCtD
Vandetanib—Pruritus—Omeprazole—Barrett's esophagus	0.000742	0.00227	CcSEcCtD
Vandetanib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000718	0.00219	CcSEcCtD
Vandetanib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000718	0.00219	CcSEcCtD
Vandetanib—Dizziness—Esomeprazole—Barrett's esophagus	0.000694	0.00212	CcSEcCtD
Vandetanib—Dizziness—Omeprazole—Barrett's esophagus	0.000694	0.00212	CcSEcCtD
Vandetanib—Vomiting—Omeprazole—Barrett's esophagus	0.000667	0.00204	CcSEcCtD
Vandetanib—Vomiting—Esomeprazole—Barrett's esophagus	0.000667	0.00204	CcSEcCtD
Vandetanib—Rash—Esomeprazole—Barrett's esophagus	0.000661	0.00202	CcSEcCtD
Vandetanib—Rash—Omeprazole—Barrett's esophagus	0.000661	0.00202	CcSEcCtD
Vandetanib—Dermatitis—Omeprazole—Barrett's esophagus	0.000661	0.00202	CcSEcCtD
Vandetanib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000661	0.00202	CcSEcCtD
Vandetanib—Headache—Esomeprazole—Barrett's esophagus	0.000657	0.00201	CcSEcCtD
Vandetanib—Headache—Omeprazole—Barrett's esophagus	0.000657	0.00201	CcSEcCtD
Vandetanib—Nausea—Esomeprazole—Barrett's esophagus	0.000623	0.0019	CcSEcCtD
Vandetanib—Nausea—Omeprazole—Barrett's esophagus	0.000623	0.0019	CcSEcCtD
Vandetanib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000107	0.000598	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—GAST—Barrett's esophagus	0.000106	0.000594	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—GAST—Barrett's esophagus	0.000105	0.000588	CbGpPWpGaD
Vandetanib—EGFR—B Cell Activation—RELA—Barrett's esophagus	0.000105	0.000587	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGES—Barrett's esophagus	0.000104	0.000583	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000103	0.00058	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000103	0.000579	CbGpPWpGaD
Vandetanib—LCK—B Cell Activation—RELA—Barrett's esophagus	0.000101	0.000565	CbGpPWpGaD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.0001	0.000563	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—PPARG—Barrett's esophagus	0.0001	0.000562	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—HGF—Barrett's esophagus	9.94e-05	0.000557	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—RELA—Barrett's esophagus	9.9e-05	0.000555	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—HGF—Barrett's esophagus	9.89e-05	0.000554	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—GAST—Barrett's esophagus	9.88e-05	0.000554	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—HGF—Barrett's esophagus	9.84e-05	0.000552	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—HGF—Barrett's esophagus	9.74e-05	0.000546	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—PPARG—Barrett's esophagus	9.69e-05	0.000543	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—GAST—Barrett's esophagus	9.53e-05	0.000534	CbGpPWpGaD
Vandetanib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	9.45e-05	0.00053	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	9.4e-05	0.000527	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—APC—Barrett's esophagus	9.26e-05	0.000519	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—RELA—Barrett's esophagus	9.25e-05	0.000519	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	9.21e-05	0.000516	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—GAST—Barrett's esophagus	9.21e-05	0.000516	CbGpPWpGaD
Vandetanib—MKNK1—Disease—APC—Barrett's esophagus	9.17e-05	0.000514	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGES—Barrett's esophagus	9.15e-05	0.000513	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	9.07e-05	0.000508	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—TP53—Barrett's esophagus	9.05e-05	0.000507	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—RELA—Barrett's esophagus	9.03e-05	0.000506	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—HGF—Barrett's esophagus	8.99e-05	0.000504	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—RELA—Barrett's esophagus	8.95e-05	0.000502	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—RELA—Barrett's esophagus	8.92e-05	0.0005	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	8.82e-05	0.000494	CbGpPWpGaD
Vandetanib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	8.69e-05	0.000487	CbGpPWpGaD
Vandetanib—BLK—Immune System—HGF—Barrett's esophagus	8.64e-05	0.000485	CbGpPWpGaD
Vandetanib—FGR—Immune System—HGF—Barrett's esophagus	8.62e-05	0.000483	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—RELA—Barrett's esophagus	8.6e-05	0.000482	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—RELA—Barrett's esophagus	8.58e-05	0.000481	CbGpPWpGaD
Vandetanib—TEK—Hemostasis—TP53—Barrett's esophagus	8.56e-05	0.00048	CbGpPWpGaD
Vandetanib—SRC—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	8.47e-05	0.000475	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—APC—Barrett's esophagus	8.47e-05	0.000475	CbGpPWpGaD
Vandetanib—ALB—Folate Metabolism—TP53—Barrett's esophagus	8.29e-05	0.000465	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—RELA—Barrett's esophagus	8.27e-05	0.000464	CbGpPWpGaD
Vandetanib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	8.19e-05	0.000459	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—SST—Barrett's esophagus	8.15e-05	0.000457	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—RELA—Barrett's esophagus	8.12e-05	0.000455	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—HGF—Barrett's esophagus	8.11e-05	0.000454	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HGF—Barrett's esophagus	7.92e-05	0.000444	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—RELA—Barrett's esophagus	7.89e-05	0.000442	CbGpPWpGaD
Vandetanib—EGFR—Direct p53 effectors—TP53—Barrett's esophagus	7.89e-05	0.000442	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CYP26A1—Barrett's esophagus	7.88e-05	0.000442	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—RELA—Barrett's esophagus	7.84e-05	0.00044	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—PPARG—Barrett's esophagus	7.82e-05	0.000438	CbGpPWpGaD
Vandetanib—VEGFA—Cellular responses to stress—TP53—Barrett's esophagus	7.75e-05	0.000435	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—APC—Barrett's esophagus	7.75e-05	0.000434	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—RELA—Barrett's esophagus	7.7e-05	0.000432	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	7.68e-05	0.00043	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—RELA—Barrett's esophagus	7.58e-05	0.000425	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	7.55e-05	0.000423	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	7.46e-05	0.000418	CbGpPWpGaD
Vandetanib—EGFR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	7.43e-05	0.000416	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—RELA—Barrett's esophagus	7.42e-05	0.000416	CbGpPWpGaD
Vandetanib—FYN—Disease—SLC9A1—Barrett's esophagus	7.4e-05	0.000415	CbGpPWpGaD
Vandetanib—PLK4—Cell Cycle—TP53—Barrett's esophagus	7.38e-05	0.000414	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SST—Barrett's esophagus	7.27e-05	0.000407	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—RELA—Barrett's esophagus	7.24e-05	0.000406	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—PPARG—Barrett's esophagus	7.22e-05	0.000405	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.2e-05	0.000404	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	7.19e-05	0.000403	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SST—Barrett's esophagus	7.19e-05	0.000403	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—HGF—Barrett's esophagus	7.18e-05	0.000402	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—PPARG—Barrett's esophagus	7.11e-05	0.000399	CbGpPWpGaD
Vandetanib—SRC—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	7.05e-05	0.000395	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	7.01e-05	0.000393	CbGpPWpGaD
Vandetanib—MKNK1—Disease—PTGS2—Barrett's esophagus	6.96e-05	0.00039	CbGpPWpGaD
Vandetanib—YES1—Immune System—HGF—Barrett's esophagus	6.95e-05	0.00039	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	6.93e-05	0.000389	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—RELA—Barrett's esophagus	6.93e-05	0.000388	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—GAST—Barrett's esophagus	6.87e-05	0.000385	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—CXCL8—Barrett's esophagus	6.82e-05	0.000382	CbGpPWpGaD
Vandetanib—EGFR—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.82e-05	0.000382	CbGpPWpGaD
Vandetanib—ABCC1—Disease—SLC9A1—Barrett's esophagus	6.78e-05	0.00038	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—SST—Barrett's esophagus	6.77e-05	0.00038	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—GAST—Barrett's esophagus	6.76e-05	0.000379	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—RELA—Barrett's esophagus	6.65e-05	0.000373	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—RELA—Barrett's esophagus	6.62e-05	0.000371	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.59e-05	0.000369	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—RELA—Barrett's esophagus	6.57e-05	0.000368	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SST—Barrett's esophagus	6.53e-05	0.000366	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—APC—Barrett's esophagus	6.42e-05	0.00036	CbGpPWpGaD
Vandetanib—EGFR—Disease—SLC9A1—Barrett's esophagus	6.39e-05	0.000358	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SST—Barrett's esophagus	6.31e-05	0.000354	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—CXCL8—Barrett's esophagus	6.24e-05	0.00035	CbGpPWpGaD
Vandetanib—LCK—Disease—SLC9A1—Barrett's esophagus	6.16e-05	0.000345	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.15e-05	0.000345	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—PTGS2—Barrett's esophagus	6.15e-05	0.000345	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—PPARG—Barrett's esophagus	6.14e-05	0.000344	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—RELA—Barrett's esophagus	6.05e-05	0.000339	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—RELA—Barrett's esophagus	5.85e-05	0.000328	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—GAST—Barrett's esophagus	5.84e-05	0.000327	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.82e-05	0.000326	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—RELA—Barrett's esophagus	5.82e-05	0.000326	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—RELA—Barrett's esophagus	5.77e-05	0.000323	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—RELA—Barrett's esophagus	5.76e-05	0.000323	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—CXCL8—Barrett's esophagus	5.7e-05	0.00032	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—SLC9A1—Barrett's esophagus	5.68e-05	0.000318	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGES—Barrett's esophagus	5.65e-05	0.000316	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—GAST—Barrett's esophagus	5.63e-05	0.000315	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—PPARG—Barrett's esophagus	5.59e-05	0.000313	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—TP53—Barrett's esophagus	5.51e-05	0.000309	CbGpPWpGaD
Vandetanib—SRC—Disease—SLC9A1—Barrett's esophagus	5.45e-05	0.000306	CbGpPWpGaD
Vandetanib—ERBB3—Disease—APC—Barrett's esophagus	5.43e-05	0.000304	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HGF—Barrett's esophagus	5.3e-05	0.000297	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	5.28e-05	0.000296	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.25e-05	0.000294	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—PPARG—Barrett's esophagus	5.24e-05	0.000294	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—RELA—Barrett's esophagus	5.21e-05	0.000292	CbGpPWpGaD
Vandetanib—LYN—Immune System—HGF—Barrett's esophagus	5.19e-05	0.000291	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—RELA—Barrett's esophagus	5.17e-05	0.00029	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HGF—Barrett's esophagus	5.16e-05	0.000289	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—RELA—Barrett's esophagus	5.14e-05	0.000288	CbGpPWpGaD
Vandetanib—FYN—Immune System—HGF—Barrett's esophagus	5.11e-05	0.000286	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—RELA—Barrett's esophagus	5.09e-05	0.000285	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	5.07e-05	0.000284	CbGpPWpGaD
Vandetanib—BLK—Immune System—RELA—Barrett's esophagus	5.02e-05	0.000281	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—RELA—Barrett's esophagus	5.02e-05	0.000281	CbGpPWpGaD
Vandetanib—FGR—Immune System—RELA—Barrett's esophagus	5e-05	0.00028	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	5e-05	0.00028	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—GAST—Barrett's esophagus	4.98e-05	0.000279	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—RELA—Barrett's esophagus	4.97e-05	0.000279	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—RELA—Barrett's esophagus	4.96e-05	0.000278	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—RELA—Barrett's esophagus	4.88e-05	0.000274	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—HGF—Barrett's esophagus	4.85e-05	0.000272	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	4.81e-05	0.000269	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CXCL8—Barrett's esophagus	4.73e-05	0.000265	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SST—Barrett's esophagus	4.71e-05	0.000264	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SST—Barrett's esophagus	4.63e-05	0.00026	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—TP53—Barrett's esophagus	4.61e-05	0.000258	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—RELA—Barrett's esophagus	4.6e-05	0.000258	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.58e-05	0.000257	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—TP53—Barrett's esophagus	4.45e-05	0.000249	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HGF—Barrett's esophagus	4.41e-05	0.000247	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—PTGS2—Barrett's esophagus	4.4e-05	0.000246	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—RELA—Barrett's esophagus	4.39e-05	0.000246	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—APC—Barrett's esophagus	4.31e-05	0.000242	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP26A1—Barrett's esophagus	4.28e-05	0.00024	CbGpPWpGaD
Vandetanib—LCK—Immune System—HGF—Barrett's esophagus	4.25e-05	0.000238	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—RELA—Barrett's esophagus	4.24e-05	0.000238	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—RELA—Barrett's esophagus	4.23e-05	0.000237	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—RELA—Barrett's esophagus	4.22e-05	0.000236	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—TP53—Barrett's esophagus	4.18e-05	0.000235	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PTGS2—Barrett's esophagus	4.12e-05	0.000231	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	4.07e-05	0.000228	CbGpPWpGaD
Vandetanib—YES1—Immune System—RELA—Barrett's esophagus	4.03e-05	0.000226	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SST—Barrett's esophagus	4e-05	0.000224	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	3.95e-05	0.000221	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SST—Barrett's esophagus	3.86e-05	0.000216	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—APC—Barrett's esophagus	3.85e-05	0.000216	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—TP53—Barrett's esophagus	3.83e-05	0.000215	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—APC—Barrett's esophagus	3.8e-05	0.000213	CbGpPWpGaD
Vandetanib—SRC—Immune System—HGF—Barrett's esophagus	3.76e-05	0.000211	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—RELA—Barrett's esophagus	3.75e-05	0.00021	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—APC—Barrett's esophagus	3.63e-05	0.000204	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—RELA—Barrett's esophagus	3.6e-05	0.000202	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—TP53—Barrett's esophagus	3.5e-05	0.000196	CbGpPWpGaD
Vandetanib—FYN—Disease—APC—Barrett's esophagus	3.5e-05	0.000196	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—APC—Barrett's esophagus	3.46e-05	0.000194	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SST—Barrett's esophagus	3.41e-05	0.000191	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—RELA—Barrett's esophagus	3.37e-05	0.000189	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—APC—Barrett's esophagus	3.34e-05	0.000187	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—TP53—Barrett's esophagus	3.32e-05	0.000186	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—TP53—Barrett's esophagus	3.3e-05	0.000185	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—TP53—Barrett's esophagus	3.27e-05	0.000183	CbGpPWpGaD
Vandetanib—ABCC1—Disease—APC—Barrett's esophagus	3.21e-05	0.00018	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CXCL8—Barrett's esophagus	3.18e-05	0.000178	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.16e-05	0.000177	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SLC9A1—Barrett's esophagus	3.08e-05	0.000173	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	3.08e-05	0.000173	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—RELA—Barrett's esophagus	3.07e-05	0.000172	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.05e-05	0.000171	CbGpPWpGaD
Vandetanib—EGFR—Disease—APC—Barrett's esophagus	3.02e-05	0.000169	CbGpPWpGaD
Vandetanib—LYN—Immune System—RELA—Barrett's esophagus	3.01e-05	0.000169	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—RELA—Barrett's esophagus	3e-05	0.000168	CbGpPWpGaD
Vandetanib—ABL1—Immune System—RELA—Barrett's esophagus	2.99e-05	0.000168	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—RELA—Barrett's esophagus	2.97e-05	0.000167	CbGpPWpGaD
Vandetanib—FYN—Immune System—RELA—Barrett's esophagus	2.96e-05	0.000166	CbGpPWpGaD
Vandetanib—LCK—Disease—APC—Barrett's esophagus	2.91e-05	0.000163	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	2.91e-05	0.000163	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TP53—Barrett's esophagus	2.9e-05	0.000163	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CXCL8—Barrett's esophagus	2.83e-05	0.000159	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CXCL8—Barrett's esophagus	2.8e-05	0.000157	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTGS2—Barrett's esophagus	2.76e-05	0.000155	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—TP53—Barrett's esophagus	2.72e-05	0.000152	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—RELA—Barrett's esophagus	2.7e-05	0.000151	CbGpPWpGaD
Vandetanib—FYN—Disease—PTGS2—Barrett's esophagus	2.66e-05	0.000149	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	2.64e-05	0.000148	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RELA—Barrett's esophagus	2.61e-05	0.000146	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PPARG—Barrett's esophagus	2.59e-05	0.000145	CbGpPWpGaD
Vandetanib—SRC—Disease—APC—Barrett's esophagus	2.58e-05	0.000145	CbGpPWpGaD
Vandetanib—EGFR—Immune System—RELA—Barrett's esophagus	2.56e-05	0.000143	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CXCL8—Barrett's esophagus	2.55e-05	0.000143	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	2.54e-05	0.000143	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—APC—Barrett's esophagus	2.49e-05	0.00014	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.49e-05	0.000139	CbGpPWpGaD
Vandetanib—LCK—Immune System—RELA—Barrett's esophagus	2.47e-05	0.000138	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CXCL8—Barrett's esophagus	2.46e-05	0.000138	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—APC—Barrett's esophagus	2.45e-05	0.000137	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTGS2—Barrett's esophagus	2.44e-05	0.000137	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TP53—Barrett's esophagus	2.41e-05	0.000135	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.31e-05	0.000129	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—Barrett's esophagus	2.3e-05	0.000129	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PPARG—Barrett's esophagus	2.28e-05	0.000128	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—Barrett's esophagus	2.21e-05	0.000124	CbGpPWpGaD
Vandetanib—SRC—Immune System—RELA—Barrett's esophagus	2.18e-05	0.000122	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—APC—Barrett's esophagus	2.12e-05	0.000119	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—APC—Barrett's esophagus	2.04e-05	0.000114	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—Barrett's esophagus	2.04e-05	0.000114	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	1.99e-05	0.000111	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—Barrett's esophagus	1.96e-05	0.00011	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TP53—Barrett's esophagus	1.95e-05	0.000109	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RELA—Barrett's esophagus	1.95e-05	0.000109	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RELA—Barrett's esophagus	1.92e-05	0.000107	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	1.87e-05	0.000105	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—Barrett's esophagus	1.83e-05	0.000103	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—APC—Barrett's esophagus	1.81e-05	0.000101	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—Barrett's esophagus	1.8e-05	0.000101	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.79e-05	0.000101	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	1.78e-05	9.99e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TP53—Barrett's esophagus	1.74e-05	9.74e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TP53—Barrett's esophagus	1.72e-05	9.63e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.66e-05	9.33e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RELA—Barrett's esophagus	1.65e-05	9.27e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TP53—Barrett's esophagus	1.63e-05	9.11e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RELA—Barrett's esophagus	1.59e-05	8.94e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TP53—Barrett's esophagus	1.56e-05	8.75e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—Barrett's esophagus	1.56e-05	8.74e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TP53—Barrett's esophagus	1.51e-05	8.46e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	1.5e-05	8.42e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RELA—Barrett's esophagus	1.41e-05	7.91e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARG—Barrett's esophagus	1.41e-05	7.89e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—Barrett's esophagus	1.33e-05	7.46e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	1.15e-05	6.44e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TP53—Barrett's esophagus	1.12e-05	6.31e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—Barrett's esophagus	1.11e-05	6.21e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TP53—Barrett's esophagus	1.11e-05	6.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TP53—Barrett's esophagus	9.57e-06	5.36e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TP53—Barrett's esophagus	9.22e-06	5.17e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TP53—Barrett's esophagus	8.16e-06	4.58e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	7.6e-06	4.26e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.98e-06	3.35e-05	CbGpPWpGaD
